整形外科与普外科医生在假体乳房再造中的结局与资源利用比较
基于美国外科医师学会国家手术质量改进计划2012至2014年数据,纳入9264例假体或组织扩张器乳房再造患者,其中90.3%由整形外科医生完成、9.7%由普外科医生完成。整形外科医生组主要并发症发生率显著更低(1.2%对2.8%,P<0.001),住院时间和手术时间也更短;两组非计划再手术、再入院及创面相关并发症无显著差异。
要点
- 整形外科医生组主要并发症1.2%,显著低于普外科医生组2.8%(P<0.001)。
- 普外科医生组住院时间与手术时间均显著长于整形外科医生组。
- 两组非计划再手术、再入院及创面并发症无显著差异。
核心结论
- 由普外科医生完成的假体乳房再造患者主要并发症显著更多。
- 整形外科医生作为乳房再造服务的主要提供者对医疗系统有益。
研究设计与样本
- 回顾性数据库研究,数据来自美国外科医师学会国家手术质量改进计划2012至2014年。
- 纳入立即假体再造或立即/延迟组织扩张器再造患者,共9264例,整形外科医生组8362例(90.3%),普外科医生组902例(9.7%)。
主要发现
- 主要并发症:整形外科医生组1.2%,普外科医生组2.8%,P<0.001。
- 非计划再手术:整形外科医生组5.3%,普外科医生组4.9%,P=0.592。
- 非计划再入院:整形外科医生组4.3%,普外科医生组3.8%,P=0.555。
- 创面裂开:整形外科医生组0.7%,普外科医生组0.6%,P=0.602;创面感染:2.9%对2.8%,P=0.866。
- 住院时间:整形外科医生组1.02±4.41天,普外科医生组1.62±4.07天,P<0.001;手术时间:164.3±97.6分钟对185.4±126.5分钟,P=0.001。
临床怎么用
- 假体乳房再造应由整形外科医生作为主要提供者,以降低主要并发症并减少资源消耗。
- 应采取措施确保整形外科医生可及并鼓励其提供乳房再造服务。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Because of lack of patient education on the importance of surgeon certification and barriers to access a plastic surgeon (PS), non-PSs are becoming more involved in providing implant-based breast reconstruction procedures. We aim to clarify differences in outcomes and resource utilization by surgical specialty for implant-based breast reconstruction. METHODS: Data were obtained from the American College of Surgeons National Surgical Quality Improvement Program database from 2012 to 2014. Patients undergoing immediate implant-based reconstruction or immediate/delayed tissue expander-based reconstruction were identified (Current Procedural Terminology codes 19340 and 19357, respectively). Outcomes studied were major and wound-based 30-day complications, operation time, unplanned readmission or reoperation, and length of hospital stay. RESULTS: We identified 9264 patients who underwent prosthesis or tissue expander-based breast reconstruction, 8362 (90.3%) by PSs and 902 (9.7%) by general surgeons (GSs). There were significant differences in major complications between specialty (1.2% PS vs 2.8% GS; P < 0.001). There were no significant differences in unplanned reoperation (5.3% PS vs 4.9% GS; P = 0.592), unplanned readmissions (4.3% PS vs 3.8% GS; P = 0.555), wound dehiscence (0.7% PS vs 0.6% GS; P = 0.602), or wound-based infection rates (2.9% PS vs 2.8% GS; P = 0.866). As it pertains to resource utilization, the GS patients had a significantly longer length of stay (1.02 ± 4.41 days PS vs 1.62 ± 4.07 days GS; P < 0.001) and operative time (164.3 ± 97.6 minutes PS vs 185.4 ± 126.5 minutes; P = 0.001) than PS patients. CONCLUSIONS: This current assessment demonstrates that patients who undergo breast implant reconstruction by a GS have significantly more major complications. It is beneficial for the health care system for PSs to be the primary providers of breast reconstruction services. Measures should be taken to ensure that PSs are available and encouraged to provide this service.
引用
- Chattha A, Muste J, Chen AD, et al. A Comparison of Outcomes and Resource Utilization Between Plastic Surgeons and General Surgeons in Implant-Based Breast Reconstruction. Ann Plast Surg. 2019. PMID: 31135507. doi:10.1097/SAP.0000000000001887
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。